Pfizer Inc. (LON:0Q1N)

Market Cap	110.56B
Revenue (ttm)	46.82B
Net Income (ttm)	7.33B
Shares Out	n/a
EPS (ttm)	1.29
PE Ratio	15.08
Forward PE	8.63
Dividend	1.31 (5.11%)
Ex-Dividend Date	Nov 7, 2025

Volume	64,615
Average Volume	196,317
Open	25.70
Previous Close	25.72
Day's Range	25.67 - 25.85
52-Week Range	20.77 - 27.88
Beta	0.43
RSI	57.88
Earnings Date	Nov 4, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Pharmaceutical Preparations
• Founded: 1849
• Employees: 81,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q1N

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD